Resistell AG closes CHF 3.5M series A financing round

New treatments like phage therapy are being used to fight the deadly risk of antibiotic resistance, and Resistell is working to speed up and improve the identification of bacteria and the prescription of the correct medicines.

We are please to share that on 07.06.2018 in Zurich, Resistell has received the Swiss Nanotechnology Startup Award for the Best Nanotechnology Startup 2018.

Last week, we competed with over 200 startups from 31 countries in final judging round at Campus Biotech in Geneva. We are pleased to inform that Resistell AG qualified to the finals!

31.05.2018 - Resistell's team has won the Venture Kick stage 2!

The Access To Medicine foundation warns that antibiotic supply chain issues are helping to fuel the rise in AMR Their solution? ‘The right products need to reach the right patients at the right time’ - exactly what Resistell is working toward.

Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed.

The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.